Attached files
| file | filename |
|---|---|
| EX-31.2 - ALTEROLA BIOTECH INC. | ex31_2.htm |
| EX-31.1 - ALTEROLA BIOTECH INC. | ex31_1.htm |
| 10-Q - ALTEROLA BIOTECH INC. | abti10q.htm |
CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND
CHIEF FINANCIAL OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Alterola Biotech, Inc. (the “Company”) on Form 10-Q for the quarter ended December 31, 2019 filed with the Securities and Exchange Commission (the “Report”), I, Tim Rogers, Chief Executive Officer and I, Larson Elmore, Interim Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
| 1. | The Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and |
| 2. | The information contained in the Report fairly presents, in all material respects, the consolidated financial condition of the Company as of the dates presented and the consolidated result of operations of the Company for the periods presented. |
| By: | /s/ Tim Rogers |
| Name: | Tim Rogers |
| Title: | Chief Executive Officer and Director |
| Date: | April 2, 2021 |
| By: | /s/ Larson Elmore |
| Name: | Larson Elmore |
| Title: | Interim Chief Financial Officer |
| Date: | April 2, 2021 |
This certification has been furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.